The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Pathogenic potential of interferon αβ in acute influenza infection
Open accessAbstract
Influenza symptoms vary from mild disease to death; however, determinants of severity are unclear. Type I interferons (IFNαβ) are recognized as key antiviral cytokines. Here we show that, surprisingly, influenza-infected 129 mice have increased lung damage, morbidity and mortality, yet higher levels of IFNαβ, than C57BL/6 mice. Consistently, IFNα treatment of influenza-infected C57BL/6 mice increases morbidity. IFNαβ receptor deficiency in 129 mice decreases morbidity, lung damage, proinflammatory cytokines and lung-infiltrating inflammatory cells, and reduces expression of the death-inducing receptor DR5 on lung epithelia and its ligand TRAIL on inflammatory monocytes. Depletion of PDCA-1+ cells or interruption of TRAIL-DR5 interaction protects infected 129 mice. Selective lack of IFNαβ signalling in stromal cells abolishes epithelial DR5 upregulation and apoptosis, reducing host susceptibility. Hence, excessive IFNαβ signalling in response to acute influenza infection can result in uncontrolled inflammation and TRAIL-DR5-mediated epithelial cell death, which may explain morbidity and has important implications for treatment of severe disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Virus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451
Functional Role of Type I and Type II Interferons in Antiviral Defense
Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia.
de Jong, M. D., Simmons, C. P., Thanh, T. T., Hien, V. M., Smith, G. J. D., Chau, T. N. B., Hoang, D. M., Van Vinh Chau, N., Khanh, T. H., Dong, V. C., et al. (2006) · Nature Medicine · doi:10.1038/nm1477 · Cited by 1,858
Plasmacytoid dendritic cells in immunity
Colonna, M., Trinchieri, G., & Liu, Y.-J. (2004) · Nature Immunology · doi:10.1038/ni1141 · Cited by 1,678
Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus.
Kobasa, D., Jones, S. M., Shinya, K., Kash, J. C., Copps, J., Ebihara, H., Hatta, Y., Hyun Kim, J., Halfmann, P., Hatta, M., et al. (2007) · Nature · doi:10.1038/nature05495 · Cited by 934
Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation
Guarda, G., Braun, M., Staehli, F., Tardivel, A., Mattmann, C., Förster, I., Farlik, M., Decker, T., Du Pasquier, R. A., Romero, P., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.006 · Cited by 933
Cheung, C., Poon, L., Lau, A., Luk, W., Lau, Y., Shortridge, K., Gordon, S., Guan, Y., & Peiris, J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11772-7 · Cited by 889
Type 1 Interferons and the Virus-Host Relationship: A Lesson in Détente
García-Sastre, A., & Biron, C. A. (2006) · Science · doi:10.1126/science.1125676 · Cited by 885
Type I interferon: friend or foe?
Trinchieri, G. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20101664 · Cited by 844
IFITM3 restricts the morbidity and mortality associated with influenza
The GenISIS Investigators, Everitt, A. R., The MOSAIC Investigators, Clare, S., Pertel, T., John, S. P., Wash, R. S., Smith, S. E., Chin, C. R., Feeley, E. M., et al. (2012) · Nature · doi:10.1038/nature10921 · Cited by 782
Persistent LCMV infection is controlled by blockade of type I interferon signaling
Teijaro, J. R., Ng, C., Lee, A. M., Sullivan, B. M., Sheehan, K. C. F., Welch, M., Schreiber, R. D., Carlos de la Torre, J., & Oldstone, M. B. A. (2013) · Science · doi:10.1126/science.1235214 · Cited by 755
Blockade of chronic type I interferon signaling to control persistent LCMV infection
Wilson, E. B., Yamada, D. H., Elsaesser, H., Herskovitz, J., Deng, J., Cheng, G., Aronow, B. J., Karp, C. L., & Brooks, D. G. (2013) · Science · doi:10.1126/science.1235208 · Cited by 709
Teijaro, J. R., Walsh, K. B., Cahalan, S., Fremgen, D. M., Roberts, E., Scott, F., Martinborough, E., Peach, R., Oldstone, M. B. A., & Rosen, H. (2011) · Cell · doi:10.1016/j.cell.2011.08.015 · Cited by 688
Isaacs, A., & Lindenmann, J. (2015) · The Journal of Immunology · doi:10.1093/jimmunol/195.5.1911 · Cited by 602
Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus
Kash, J. C., Tumpey, T. M., Proll, S. C., Carter, V., Perwitasari, O., Thomas, M. J., Basler, C. F., Palese, P., Taubenberger, J. K., García-Sastre, A., et al. (2006) · Nature · doi:10.1038/nature05181 · Cited by 551
Yan, N., & Chen, Z. J. (2012) · Nature Immunology · doi:10.1038/ni.2229 · Cited by 532
Type I Interferon Production Enhances Susceptibility to Listeria monocytogenes Infection
O'Connell, R. M., Saha, S. K., Vaidya, S. A., Bruhn, K. W., Miranda, G. A., Zarnegar, B., Perry, A. K., Nguyen, B. O., Lane, T. F., Taniguchi, T., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040712 · Cited by 489
Jacquelin, B., Mayau, V., Targat, B., Liovat, A.-S., Kunkel, D., Petitjean, G., Dillies, M.-A., Roques, P., Butor, C., Silvestri, G., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci40093 · Cited by 481
GeurtsvanKessel, C. H., Willart, M. A. M., van Rijt, L. S., Muskens, F., Kool, M., Baas, C., Thielemans, K., Bennett, C., Clausen, B. E., Hoogsteden, H. C., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071365 · Cited by 480
Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice
Shahangian, A., Chow, E. K., Tian, X., Kang, J. R., Ghaffari, A., Liu, S. Y., Belperio, J. A., Cheng, G., & Deng, J. C. (2009) · Journal of Clinical Investigation · doi:10.1172/jci35412 · Cited by 479
Mordstein, M., Neugebauer, E., Ditt, V., Jessen, B., Rieger, T., Falcone, V., Sorgeloos, F., Ehl, S., Mayer, D., Kochs, G., et al. (2010) · Journal of Virology · doi:10.1128/jvi.00272-10 · Cited by 443
You, Y., Richer, E. J., Huang, T., & Brody, S. L. (2002) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00169.2002 · Cited by 442
Mandl, J. N., Barry, A. P., Vanderford, T. H., Kozyr, N., Chavan, R., Klucking, S., Barrat, F. J., Coffman, R. L., Staprans, S. I., & Feinberg, M. B. (2008) · Nature Medicine · doi:10.1038/nm.1871 · Cited by 383
Herold, S., Steinmueller, M., von Wulffen, W., Cakarova, L., Pinto, R., Pleschka, S., Mack, M., Kuziel, W. A., Corazza, N., Brunner, T., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080201 · Cited by 376
Baskin, C. R., Bielefeldt-Ohmann, H., Tumpey, T. M., Sabourin, P. J., Long, J. P., García-Sastre, A., Tolnay, A.-E., Albrecht, R., Pyles, J. A., Olson, P. H., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813234106 · Cited by 361
Asselin-Paturel, C., Brizard, G., Pin, J.-J., Brière, F., & Trinchieri, G. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6466 · Cited by 360
Mordstein, M., Kochs, G., Dumoutier, L., Renauld, J.-C., Paludan, S. R., Klucher, K., & Staeheli, P. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000151 · Cited by 325
Antonelli, L. R. V., Gigliotti Rothfuchs, A., Gonçalves, R., Roffê, E., Cheever, A. W., Bafica, A., Salazar, A. M., Feng, C. G., & Sher, A. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40817 · Cited by 292
Type I IFN Modulates Innate and Specific Antiviral Immunity
Durbin, J. E., Fernandez-Sesma, A., Lee, C.-K., Rao, T. D., Frey, A. B., Moran, T. M., Vukmanovic, S., García-Sastre, A., & Levy, D. E. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4220 · Cited by 286
The Role of Interferon in Influenza Virus Tissue Tropism
García-Sastre, A., Durbin, R. K., Zheng, H., Palese, P., Gertner, R., Levy, D. E., & Durbin, J. E. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8550-8558.1998 · Cited by 286
Crotta, S., Davidson, S., Mahlakoiv, T., Desmet, C. J., Buckwalter, M. R., Albert, M. L., Staeheli, P., & Wack, A. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003773 · Cited by 269
Self-citationInteferons pen the JAK–STAT pathway
Schindler, C., & Plumlee, C. (2008) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2008.08.010 · Cited by 256
Interferon induces a unique protein in mouse cells bearing a gene for resistance to influenza virus.
Horisberger, M. A., Staeheli, P., & Haller, O. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.7.1910 · Cited by 245
Innate immune responses to influenza A H5N1: friend or foe?
Peiris, J. S. M., Cheung, C. Y., Leung, C. Y. H., & Nicholls, J. M. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.09.004 · Cited by 232
Högner, K., Wolff, T., Pleschka, S., Plog, S., Gruber, A. D., Kalinke, U., Walmrath, H.-D., Bodner, J., Gattenlöhner, S., Lewe-Schlosser, P., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003188 · Cited by 227
Host Genetic Background Strongly Influences the Response to Influenza A Virus Infections
Srivastava, B., Błażejewska, P., Heßmann, M., Bruder, D., Geffers, R., Mauel, S., Gruber, A. D., & Schughart, K. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004857 · Cited by 215
Herbeuval, J.-P. (2005) · Blood · doi:10.1182/blood-2005-03-1243 · Cited by 211
Protective Role of Beta Interferon in Host Defense against Influenza A Virus
Koerner, I., Kochs, G., Kalinke, U., Weiss, S., & Staeheli, P. (2007) · Journal of Virology · doi:10.1128/jvi.01718-06 · Cited by 201
The Role of Alpha/Beta and Gamma Interferons in Development of Immunity to Influenza A Virus in Mice
Price, G. E., Gaszewska-Mastarlarz, A., & Moskophidis, D. (2000) · Journal of Virology · doi:10.1128/jvi.74.9.3996-4003.2000 · Cited by 192
Rotger, M., Dalmau, J., Rauch, A., McLaren, P., Bosinger, S. E., Martinez, R., Sandler, N. G., Roque, A., Liebner, J., Battegay, M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45235 · Cited by 187
Herbeuval, J.-P., Nilsson, J., Boasso, A., Hardy, A. W., Kruhlak, M. J., Anderson, S. A., Dolan, M. J., Dy, M., Andersson, J., & Shearer, G. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600363103 · Cited by 186
The Viral Nucleoprotein Determines Mx Sensitivity of Influenza A Viruses
Zimmermann, P., Mänz, B., Haller, O., Schwemmle, M., & Kochs, G. (2011) · Journal of Virology · doi:10.1128/jvi.00712-11 · Cited by 184
Boon, A. C. M., deBeauchamp, J., Hollmann, A., Luke, J., Kotb, M., Rowe, S., Finkelstein, D., Neale, G., Lu, L., Williams, R. W., et al. (2009) · Journal of Virology · doi:10.1128/jvi.00514-09 · Cited by 184
Hardy, A. W., Graham, D. R., Shearer, G. M., & Herbeuval, J.-P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707244104 · Cited by 173
Inflammasomes as mediators of immunity against influenza virus
Pang, I. K., & Iwasaki, A. (2011) · Trends in Immunology · doi:10.1016/j.it.2010.11.004 · Cited by 170
Zeng, H., Goldsmith, C., Thawatsupha, P., Chittaganpitch, M., Waicharoen, S., Zaki, S., Tumpey, T. M., & Katz, J. M. (2007) · Journal of Virology · doi:10.1128/jvi.01134-07 · Cited by 160
Influenza A Virus Strains Differ in Sensitivity to the Antiviral Action of Mx-GTPase
Dittmann, J., Stertz, S., Grimm, D. G., Steel, J., García‐Sastre, A., Haller, O., & Kochs, G. (2008) · Journal of Virology · doi:10.1128/jvi.01753-07 · Cited by 157
Epidemiology of Cases of H5N1 Virus Infection in Indonesia, July 2005–June 2006
Sedyaningsih, E. R., Isfandari, S., Setiawaty, V., Rif’ati, L., Harun, S., Purba, W., Imari, S., Giriputra, S., Blair, P. J., Putnam, S. D., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/519692 · Cited by 143
Seroevidence for H5N1 Influenza Infections in Humans: Meta-Analysis
Wang, T. T., Parides, M. K., & Palese, P. (2012) · Science · doi:10.1126/science.1218888 · Cited by 142
Evidence for a Heritable Predisposition to Death Due to Influenza
Albright, F. S., Orlando, P. L., Pavia, A. T., Jackson, G. G., & Cannon‐Albright, L. (2007) · The Journal of Infectious Diseases · doi:10.1086/524064 · Cited by 131
Enhanced virus resistance of transgenic mice expressing the human MxA protein
Pavlovic, J., Arzet, H. A., Hefti, H. P., Frese, M., Rost, D., Ernst, B., Kolb, E., Staeheli, P., & Haller, O. (1995) · Journal of Virology · doi:10.1128/jvi.69.7.4506-4510.1995 · Cited by 130
TRAIL: a multifunctional cytokine
Schaefer, U., Voloshanenko, O., Willen, D., & Walczak, H. (2007) · Frontiers in bioscience · doi:10.2741/2354 · Cited by 123
The Role of Host Genetics in Susceptibility to Influenza: A Systematic Review
Horby, P., Nguyen, N., Dunstan, S. J., & Baillie, J. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033180 · Cited by 112
van Grevenynghe, J., Cubas, R. A., Noto, A., DaFonseca, S., He, Z., Peretz, Y., Filali-Mouhim, A., Dupuy, F. P., Procopio, F. A., Chomont, N., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci59211 · Cited by 111
Early Control of H5N1 Influenza Virus Replication by the Type I Interferon Response in Mice
Szretter, K. J., Gangappa, S., Belser, J. A., Zeng, H., Chen, H., Matsuoka, Y., Sambhara, S. R., Swayne, D. E., Tumpey, T. M., & Katz, J. M. (2009) · Journal of Virology · doi:10.1128/jvi.02144-08 · Cited by 103
Plasmacytoid Dendritic Cells Are Dispensable during Primary Influenza Virus Infection
Wolf, A. I., Buehler, D. G., Hensley, S. E., Cavanagh, L. L., Wherry, E. J., Kastner, P., Chan, S. H., & Weninger, W. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.2.871 · Cited by 102
Kugel, D., Kochs, G., Obojes, K., Roth, J., Kobinger, G., Kobasa, D., Haller, O., Staeheli, P., & von Messling, V. (2009) · Journal of Virology · doi:10.1128/jvi.02453-08 · Cited by 101
Protective role of interferon-induced Mx GTPases against influenza viruses
Haller, O., Staeheli, P., & Kochs, G. (2009) · Scientific and Technical Review (World Organisation for Animal Health) · doi:10.20506/rst.28.1.1867 · Cited by 97
TRAIL and Other TRAIL Receptor Agonists as Novel Cancer Therapeutics
Falschlehner, C., Ganten, T. M., Koschny, R., Schaefer, U., & Walczak, H. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-89520-8_14 · Cited by 94
Interferons, Mx Genes, and Resistance to Influenza Virus
Horisberger, M. A. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm/152.4_pt_2.s67 · Cited by 85
Pandemic (H1N1) 2009 Virus and Down Syndrome Patients
Pérez‐Padilla, R., Fernández, R., García-Sancho, C., Franco‐Marina, F., Aburto‐Oropeza, O., López‐Gatell, H., & Bojórquez, I. (2010) · Emerging infectious diseases · doi:10.3201/eid1608.091931 · Cited by 84
Lin, L., Gorke, S., Rau, S. J., Zeisel, M. B., Hildt, E., Himmelsbach, K., Carvajal-Yepes, M., Huber, R., Wakita, T., Schmitt-Graeff, A. H., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4926 · Cited by 69
Protection from lethal influenza virus challenge by oral type 1 interferon
Beilharz, M. W., Cummins, J. Μ., & Bennett, A. L. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.02.019 · Cited by 66
Langlois, R. A., & Legge, K. L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902984 · Cited by 65
Cillóniz, C., Pantin‐Jackwood, M. J., Ni, C., Carter, V. S., Korth, M. J., Swayne, D. E., Tumpey, T. M., & Katze, M. G. (2011) · Journal of Virology · doi:10.1128/jvi.06156-11 · Cited by 44
Brincks, E. L., Gurung, P., Langlois, R. A., Hemann, E. A., Legge, K. L., & Griffith, T. S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002241 · Cited by 43
Enhanced sensitivity of trisomy 21 monocytes to the maturation-inhibiting effect of interferon
Epstein, L. B., Lee, S. H. S., & Epstein, C. J. (1980) · Cellular Immunology · doi:10.1016/0008-8749(80)90017-9 · Cited by 41
Broers, C. J. M., Gemke, R. J. B. J., Weijerman, M. E., van der Sluijs, K., & van Furth, A. M. (2011) · Journal of Clinical Immunology · doi:10.1007/s10875-011-9625-4 · Cited by 38
Type I Interferons Increase Host Susceptibility to Trypanosoma cruzi Infection
Chessler, A.-D. C., Caradonna, K. L., Da’dara, A. A., & Burleigh, B. A. (2011) · Infection and Immunity · doi:10.1128/iai.01176-10 · Cited by 38
TRAIL: not just for tumors anymore?
Benedict, C. A., & Ware, C. F. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20122235 · Cited by 37
Pelletier, A., Guimont‐Desrochers, F., Ashton, M. P., Brodnicki, T. C., & Lesage, S. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102136 · Cited by 9
Cited by
Type I interferons in infectious disease
McNab, F., Mayer-Barber, K., Sher, A., Wack, A., & O'Garra, A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3787 · Cited by 2,780
Self-citationChannappanavar, R., Fehr, A. R., Vijay, R., Mack, M., Zhao, J., Meyerholz, D. K., & Perlman, S. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.01.007 · Cited by 1,419
The multifaceted biology of plasmacytoid dendritic cells
Swiecki, M., & Colonna, M. (2015) · Nature Reviews Immunology · doi:10.1038/nri3865 · Cited by 1,131
Phetsouphanh, C., Darley, D. R., Wilson, D. B., Howe, A., Munier, C. M. L., Patel, S. K., Juno, J. A., Burrell, L. M., Kent, S. J., Dore, G. J., et al. (2022) · Nature Immunology · doi:10.1038/s41590-021-01113-x · Cited by 1,015
Kuriakose, T., Man, S. M., Subbarao Malireddi, R. K., Karki, R., Kesavardhana, S., Place, D. E., Neale, G., Vogel, P., & Kanneganti, T.-D. (2016) · Science Immunology · doi:10.1126/sciimmunol.aag2045 · Cited by 818
Metadata
- Authors
- Davidson, S., Crotta, S., McCabe, T. M., & Wack, A.
- Venue
- Nature Communications
- Published
- 2014-05-21
- Volume
- 5
- Issue
- 1
- Pages
- 3864-3864
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W1983483525
- Cited by
- 369
- References
- 71
- FWCI
- 10.76
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.